In estrogen receptor (ER)-positive breast cancer cells, HK2 suppresses mTOR activity through an interaction with mTOR, which promotes autophagy and chemoresistance to tamoxifen (Liu et al., 2019). The gene discussed is MTOR; the disease is breast carcinoma.